Search Results
Jun 22, 2026, 11:07 ET Digital Health Tools Are Reshaping Healthcare in the United States
Segev, NYU Langone researchers involved in the study were lead investigator Jane J. Long, MD, and co-investigators Mara A. McAdams DeMarco, PhD; Mark D. Schwartz, MD; Joshua Chodosh, MD; and Eric K. Oermann, MD.Dr. Mankowski was recently elected to serve on the governing board of Epic Cosmos. Dr.
More news about: NYU Langone Health System
Jun 22, 2026, 11:00 ET The American Board of Medical Specialties Announces 2026 Service Award Recipients
has been influential in advancing certification approaches within pediatrics and beyond.ABMS Edward M. Jackson, MD – Derrick T. Vail, MD Award: Daniel J. Cole, MDNamed for Drs. Derrick T. Vail and Edward M. Jackson, two ophthalmologists credited with creating the concept
More news about: American Board of Medical Specialties
Jun 22, 2026, 11:00 ET Michels Family Donates $27 Million to the Medical College of Wisconsin to Expand Personalized Cancer Care, Accelerate Cancer Research
John R. Raymond, Sr., MD, MCW's president and CEO.A ceremony to dedicate the building will be held this fall.Read more:
More news about: Medical College of Wisconsin
Jun 22, 2026, 09:55 ET LATEST JOURNAL IMPACT FACTORS AFFIRM JMIR PUBLICATIONS' FIELD LEADERSHIP
4.0."These results belong to the researchers, editors, and staff behind every JMIR Publications journal," says Tiffany I Leung, MPH, MD, FAMIA, Scientific Editorial Director at JMIR Publications. "An impact factor reflects how often research is cited; what stands behind it is the rigor
More news about: JMIR Publications
Jun 22, 2026, 09:01 ET PrescriberPoint Expands Leadership Team, Appointing Steven Strongwater, M.D., as Chief Medical Officer
June 22, 2026 /PRNewswire/ -- PrescriberPoint, the AI point-of-care platform, today announced the appointment of Steven Strongwater, MD, as chief medical officer. In this newly established position, Dr. Strongwater will guide the Company's clinical strategy and foster relationships with
More news about: PrescriberPoint
Jun 22, 2026, 09:00 ET Choice Hotels International Launches Detours Worth Taking Guide to Help Travelers Explore More on Their Summer Road Trip
discoveries – paired with nearby Choice Hotel properties for convenient stays along the wayNORTH BETHESDA, Md., June 22, 2026 /PRNewswire/ -- As millions of Americans hit the road this summer, Choice Hotels International,
More news about: Choice Hotels International, Inc.
Jun 22, 2026, 09:00 ET EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots
Click HereThe session will be presented by Prof. Jeffrey Rosenfeld, MD, PhD, FAAN, Professor of Neurology and Director of the Neuromuscular ALS/MND Program at Loma Linda University School of Medicine. With more than 30
More news about: NeuroSense
Jun 22, 2026, 08:54 ET Howard County Economic Development Authority Selects Homegrown Technology Company App Beacon to Power Community Engagement Across Howard County's Business and Innovation Ecosystem
COLUMBIA, Md., June 22, 2026 /PRNewswire/ -- The Howard County Economic Development Authority (HCEDA) has selected App Beacon to power its community engagement platforms for both Howard County business support initiatives and
More news about: App Beacon
Jun 22, 2026, 08:48 ET Vigo MD Launches Telehealth Platform Designed to Modernize Men's Sexual Wellness Care
personalized treatment, and convenient access to care. Vigo MD aims to bring those benefits to men's sexual wellness through a patient-centered approach that emphasizes clinical oversight, accessibility, and discretion.About Vigo MDVigo MD is a men's telehealth platform focused on helping patients
More news about: Vigo MD
Jun 22, 2026, 08:44 ET Brave Healer Productions Releases Om La La, a Timely Positivity Guidebook
BETHESDA, Md., June 22, 2026 /PRNewswire/ -- Brave Healer Productions proudly announces the release of
More news about: Brave Healer Productions
Jun 22, 2026, 08:30 ET PleoPharma, Inc. to Present at BIO International Convention 2026
Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. HHS Publication No. PEP25-07-007. Rockville, MD: SAMHSA; 2025.
More news about: PleoPharma, Inc
Jun 22, 2026, 08:00 ET Brenig Therapeutics to Present AI-Enabled Design of a Brain-Penetrant NLRP3 Inhibitor at Keystone Symposia Neuroinflammation in Health and Disease
exposure."This is not a theoretical engine—it has already delivered clinical-stage assets with genuinely differentiated profiles," said Megan McGill, MD, PhD, Chief Executive Officer of Brenig Therapeutics. "BT-409 is exactly what we set out to create: a brain-penetrant therapy directed at the neuroinflammatory
More news about: Brenig Therapeutics Inc
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
dermatitis and inflammatory bowel disease. Seed financed by Sofinnova Partners, Bionyra was co-founded by Sofinnova Partners and Frédéric Marrache, MD, PhD, MBA, a former Sanofi R&D executive with deep immunology expertise. The company is committed to overcoming the limitations of existing therapies
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
dermatitis and inflammatory bowel disease. Seed financed by Sofinnova Partners, Bionyra was co-founded by Sofinnova Partners and Frédéric Marrache, MD, PhD, MBA, a former Sanofi R&D executive with deep immunology expertise. The company is committed to overcoming the limitations of existing therapies
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical anuncia un acuerdo de licencia con Bionyra Pharma
enfermedad inflamatoria intestinal. Financiada inicialmente por Sofinnova Partners, Bionyra fue cofundada por Sofinnova Partners y Frédéric Marrache, MD, PhD, MBA, exejecutivo de I+D de Sanofi con amplia experiencia en inmunología. La compañía se compromete a superar las limitaciones de las terapias existentes
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 07:30 ET REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II
accelerated approval pathway The Company expects to resubmit the BLA in Q3 2026 ROCKVILLE, Md., June 22, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it has aligned with the U.S. Food
More news about: REGENXBIO Inc.
Jun 22, 2026, 07:00 ET Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer ("CMO")
content:https://www.prnewswire.com/news-releases/biond-biologics-appoints-giovanni-selvaggi-md-as-chief-medical-officer-cmo-302806141.htmlSOURCE
More news about: Biond Biologics Ltd.
Jun 22, 2026, 07:00 ET Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
"People living with aggressive cancers often face a shortage of treatment choices," said Lykke Hinsch Gylvin, MD, Chief Medical Officer, Boehringer Ingelheim. "With the launch of these trials, we are advancing our precision oncology ambitions to move targeted therapies
More news about: Boehringer Ingelheim
Jun 22, 2026, 04:23 ET The Search For India's Next Breakthrough Innovations Begins As Marico Innovation Foundation Invites Applications For Indian Innovation Icons 2027
Aayog, former President of Nasscom and former Vice President & MD, Intel South Asia; Dr. Ashish Lele, Director, CSIR-National Chemical Laboratory; Prabha Narasimhan, MD & CEO, Colgate-Palmolive India; Ravi Mariwala, Chairman and MD, Smaart Water; Sanjiv Kaul, Senior Partner, ChrysCapitall.The
More news about: Marico Innovation Foundation
Jun 21, 2026, 20:00 ET Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
and 14 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard of industry
More news about: Innovent Biologics
Jun 20, 2026, 16:30 ET Most People Seeking a Kidney Transplant Never Reach the Waitlist
Husain, MD, MPH; Sommer E. Gentry, PhD; Bonnie E. Lonze, MD, PhD; Sunjae Bae, MD, PhD; Babak J. Orandi, MD, PhD; Mara A. McAdams DeMarco, PhD; and Dorry L. Segev, MD, PhD. Other study co-investigators were Rachel Patzer, PhD, MPH, at Indiana University in Indianapolis, and David Axelrod, MD, at University
More news about: NYU Grossman School of Medicine and NYU Langone Health
Jun 20, 2026, 05:45 ET 5paisa Capital Launches AlgoSpace: Algo Trading for Everyone, Made Simple and Accessible
ecosystem, AlgoSpace by 5paisa removes friction at every step - making algo trading intuitive, efficient, and accessible. Commenting on the launch, Gaurav Seth, MD & CEO, 5paisa Capital, said: "At 5paisa, our focus has always been on simplifying advanced trading tools for retail India. With AlgoSpace,
More news about: 5paisa Capital
Jun 19, 2026, 09:28 ET Align ENT + Allergy Partners with Michigan Ear Institute and Lakeshore ENT to Expand Physician-Led Care in Michigan and Ohio
innovation led by its nine highly regarded physicians."This partnership reflects an exciting next chapter for our practice," said Dennis I. Bojrab, MD, partner physician at Michigan Ear Institute. "Joining Align allows us to preserve what makes MEI unique while gaining the resources and infrastructure
More news about: Align ENT + Allergy
Jun 19, 2026, 09:00 ET WTOP News Names Dynanet A Winner Of The Greater Washington Area Top Workplaces 2026 Award
ELKRIDGE, Md., June 19, 2026 /PRNewswire/ -- Dynanet has been recognized as a Top Workplaces 2026 honoree by WTOP News. The designation is based entirely on confidential employee feedback collected by Energage, a third-party
More news about: Dynanet Corporation
Jun 19, 2026, 08:00 ET World's 1st HIV-to-HIV Lung Transplant Performed at NYU Langone Health
Sapna Mehta, MD, clinical director of
More news about: NYU Langone Health